USPTO serial 79307471
BRAVE ANALYTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 25, 2022
- Examiner
- MASON, JARED MICHAEL
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BRAVE ANALYTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AT
AT
AT
AT
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Measuring, detecting, monitoring and controlling devices, namely, measuring tapes; optical apparatus and instruments, namely, optical mirrors; optical inspection apparatus for industrial use; apparatus and instruments for physics, namely, photometers; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; diagnostic apparatus for the detection of pathogens for laboratory or research use; filters for blood and blood components for laboratory experiments; liquid chromatography apparatus for laboratory use; apparatus and instruments for research purposes, namely, microscopes; apparatus for automatic chromatography for laboratory use; laboratory apparatus and instruments, namely, pyrometers; laboratory instruments, other than for medical use, namely thermometers; particle classifying apparatus, namely, electrostatic precipitators; mass spectrometry apparatus; separating apparatus for laboratory use in the nature of magnetic separators; ultramicroscopes; scientific apparatus and instruments, namely, hydrometers; nanoparticle size analysers; automatic dosage apparatus, namely, machines for dispensing pre-determined dosages of medication; image analyzers being scanners; diagnostic devices, not for medical purposes, namely, diagnostic apparatus for testing food; diagnostic apparatus, not for medical purposes, namely, diagnostic apparatus for the detection of pathogens for laboratory or research use; dosage dispensers, namely, machines for dispensing pre-determined dosages of medication; control apparatus and instruments being lighting control apparatus; measuring devices and apparatus, namely, measuring rules; liquid dosage devices that measure the amounts to be dispensed, namely, machines for dispensing pre-determined dosages of medication; flowmeters; optical measurement apparatus, namely, electro-optical instruments for use in inspection and measurement of industrial components; precision measuring apparatus, namely, precision theodolites; testing and quality control devices, namely, sensing and signaling devices for measurement and quality control of materials processing by laser; testing apparatus not for medical purposes in the nature of testing apparatus for testing printed circuit boards; instruments for measuring milk quality parameters; sensors, detectors and monitoring instruments and apparatus, namely, pressure sensors; process control devices, namely, signal conditioning and communication devices for industrial process control; electronic process control apparatus, namely, signal conditioning and communication devices for industrial process control; electronic process control instruments, namely, signal conditioning and communication devices for industrial process control | ACTIVE | — |
| 042 | Process monitoring for quality assurance in the field of pharmaceuticals; scientific and technological research services in the field of pharmaceuticals; testing of materials; authentication of diamonds; quality control for others; evaluation of pharmaceutical products; quality control of services; carrying out technical tests on drugs being testing of pharmaceuticals; technical measuring and testing services, namely, greenhouse gas emission measuring and analysis; quality control testing for others; implementation of water analyzes being water analysis services; research and development of new products for others; material testing and analysis; product quality inspection, namely, technology supervision and inspection in the field of product quality control; quality assessment being quality control for others; quality control for others; quality inspection for pharmaceutical products; analytical laboratory services in the field of chemistry; consultancy in the field of industrial research in the field of chemistry; advice in the field of technological development in the field of chemistry; advisory services relating to the design of scientific instruments; providing information about chemical industrial analysis and research services; blood analysis for scientific research use; research laboratory services in the field of optics; implementation of technical feasibility studies being conducting scientific feasibility studies; implementation of laboratory analyzes in the field of chemistry; design and development of medical technology devices; design and development of technical products; scientific research in the field of measurement technology; scientific research and development services in the field of biotechnology; scientific industrial analysis and scientific industrial research services in the field of chemistry; medical and pharmaceutical research services; radiation measurement services; technical advice in the field of pollution detection; water analysis; scientific advisory services in the field of chemistry; scientific research and analysis in the field of chemistry; technical condition measurement for measuring, testing and checking the temperature, pressure, quantity and concentration of liquids; technical condition measurement for measuring, testing and checking the temperature, pressure, quantity and concentration of lubricants; technical condition monitoring for measuring, testing and checking the temperature, pressure, quantity and concentration regarding oils | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BRAVE Analytics GmbH
- Other trademarks owned by BRAVE Analytics GmbH
- Other trademarks owned by Ing. Dr. Christian HILL, MA
- Other trademarks owned by Ing. Dr. Christian HILL, MA
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named BRAVE ANALYTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 24, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 1, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 8, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 8, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 25, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 25, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 25, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 9, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 9, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 20, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 1, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 17, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 17, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 17, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 17, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 17, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 17, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 3, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 9, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 9, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 2, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 2, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 1, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |